Skip to main content
. Author manuscript; available in PMC: 2024 Mar 27.
Published in final edited form as: N Engl J Med. 2015 Feb 26;372(9):825–834. doi: 10.1056/NEJMoa1408913

Table 2. Adjusted U.S. National Estimates of Burden and Incidence of CDI, 2011.

Demographic Characteristic Community-Associated CDI* Health Care–Associated CDI All CDI
Estimated No. of Cases Incidence per 100,000 Persons Estimated No. of Cases Incidence per 100,000 Persons Estimated No. of Cases Incidence per 100,000 Persons
All cases 159,700 (132,900–186,000) 51.9 (43.2–60.5) 293,300 (264,200–322,500) 95.3 (85.9–104.8) 453,000 (397,100–508,500) 147.2 (129.1–165.3)
Sex
 Male 64,300 (52,800–75,300) 42.5 (34.8–49.8) 132,700 (118,700–146,700) 87.7 (78.5–97.0) 197,000 (171,500–222,000) 130.2 (113.3–146.8)
 Female 95,400 (80,100–110,700) 61.0 (51.2–70.8) 160,600 (145,500–175,800) 102.7 (93.1–112.5) 256,000 (225,600–286,500) 163.8 (144.3–183.3)
Age group
 1–17 yr 12,500 (10,000–15,000) 17.9 (14.1–21.4) 4400 (3200–5800) 6.3 (4.6–8.3) 16,900 (13,200–20,800) 24.2 (18.7–29.7)
 18–44 yr 35,600 (26,000–39,200) 28.7 (22.9–34.5) 20,800 (16,700–24,800) 18.3 (14.7–21.9) 53,400 (42,700–64,000) 47.0 (37.6–56.4)
 45–64 yr 54,100 (45,600–62,600) 65.4 (55.1–75.6) 68,800 (61,000–76,600) 83.1 (73.7–92.5) 122,900 (106,600–139,200) 148.5 (128.8–168.1)
 ≥65 yr 60,500 (51,300–69,200) 146.2 (124.0–167.2) 193,300 (183,300–215,300) 481.5 (442.8–520.1) 259,800 (234,600–284,500) 627.7 (566.8–687.3)
Race
 White 138,100 (118,500–157,700) 57.4 (49.2–65.5) 259,900 (230,100–273,800) 104.7 (95.6–113.8) 390,000 (348,600–431,500) 162.1 (144.8–179.3)
 Nonwhite 21,600 (14,400–28,300) 32.2 (21.5–42.2) 41,400 (34,100–48,700) 61.8 (50.9–72.7) 63,000 (48,500–77,000) 94.0 (72.4–114.9)
*

Data for community-associated Clostridium difficile infection (CDI) were adjusted for age, sex, race, and a rate of use of nucleic acid amplification test (NAAT) of 52%. Ranges in parentheses are 95% confidence intervals.

Data for health care–associated CDI were adjusted for age, inpatient days, and a rate of use of NAAT of 52%.

Race was imputed for 18.7% of the observed cases of C. difficile infection.